Continuing risk of bluetongue

The pharmaceutical industry rose magnificently to the challenge posed by the incursion of bluetongue virus serotype 8 (BTV-8), and has since adapted its response to deal with the increasing threat of BTV-1, by producing killed vaccines that have provided the only feasible control strategy to reduce...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Veterinary record 2010-05, Vol.166 (18), p.570-570
Hauptverfasser:	Roger, Paul, Clayton, Nick, Hateley, Gareth
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Animals, Domestic Bluetongue - epidemiology Bluetongue - prevention & control Bluetongue - transmission Bluetongue virus - classification Disease Outbreaks - prevention & control Disease Outbreaks - veterinary Europe - epidemiology Immunization Livestock Risk Factors Sentinel Surveillance - veterinary Serotyping - veterinary Sheep United Kingdom - epidemiology Vaccination - veterinary Vaccines
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The pharmaceutical industry rose magnificently to the challenge posed by the incursion of bluetongue virus serotype 8 (BTV-8), and has since adapted its response to deal with the increasing threat of BTV-1, by producing killed vaccines that have provided the only feasible control strategy to reduce disease and to gradually eliminate its threat.
ISSN:	0042-4900 2042-7670
DOI:	10.1136/vr.c2310